欧莱雅12月8日宣布,以未披露金额从由EQT牵头的财团手中收购高德美(Galderma)额外10%股权。此次交易后,欧莱雅对高德美的持股比例增至20%。鉴于此次增资,高德美董事会拟自2026年年度股东大会起,提名两位来自欧莱雅的非独立董事候选人,以取代EQT牵头的财团。
欧莱雅12月8日宣布,以未披露金额从由EQT牵头的财团手中收购高德美(Galderma)额外10%股权。此次交易后,欧莱雅对高德美的持股比例增至20%。鉴于此次增资,高德美董事会拟自2026年年度股东大会起,提名两位来自欧莱雅的非独立董事候选人,以取代EQT牵头的财团。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.